The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy
Restricting hypertrophic heart growth in response to pathologic overload is an unmet therapeutic need. Here, the authors show that blocking Ca2+signaling controlled by the transport protein PMCA4 in cardiac fibroblasts enhances secretion of a potent Wnt signaling inhibitor, sFRP2, and prevents the d...
Guardado en:
Autores principales: | Tamer M. A. Mohamed, Riham Abou-Leisa, Nicholas Stafford, Arfa Maqsood, Min Zi, Sukhpal Prehar, Florence Baudoin-Stanley, Xin Wang, Ludwig Neyses, Elizabeth J. Cartwright, Delvac Oceandy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3181bc8460874c778601d9d69e9cba89 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia
por: Nicholas Stafford, et al.
Publicado: (2021) -
DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy
por: Carolina M. Greco, et al.
Publicado: (2016) -
Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure
por: Seitaro Nomura, et al.
Publicado: (2018) -
Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy
por: Troncoso,Mayarling Francisca, et al.
Publicado: (2021) -
Polycystin-1 is required for insulin-like growth factor 1-induced cardiomyocyte hypertrophy.
por: Carolina Fernández, et al.
Publicado: (2021)